Yilmaz et al. [20] found that serum ZAG concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (NAFLD) after stepwise linear regression analysis. This evidence concerns the gene AZGP1 and metabolic dysfunction-associated steatotic liver disease.